Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Congyi Niu"'
Autor:
Lei Tao, Muhammad Asad Farooq, Yaoxin Gao, Li Zhang, Congyi Niu, Iqra Ajmal, Ying Zhou, Cong He, Guixia Zhao, Jie Yao, Mingyao Liu, Wenzheng Jiang
Publikováno v:
Cancers, Vol 12, Iss 9, p 2612 (2020)
B cell aplasia caused by “on-target off-tumor” toxicity is one of the clinical side effects during CD19-targeted chimeric antigen receptor (CAR) T (CD19-CAR-T) cells treatment for B cell malignancies. Persistent B cell aplasia was observed in all
Externí odkaz:
https://doaj.org/article/939897c6e2594f01bf399073c5961e7c
Autor:
Yuedi Wang, Yiyuan Gao, Congyi Niu, Bo Wang, Shushu Zhao, Gils Roex, Jiawen Qian, Jingbo Qie, Lin Chen, Chenhe Yi, Sébastien Anguille, Jie Liu, Feifei Luo, Yiwei Chu
Publikováno v:
Cancer immunology and immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy achieves great success for hematological malignancies. However, clinical trials have revealed some limitations in both improving the efficacy and reducing the relapse, which calls for innovative strategi
Autor:
Congyi Niu, Cong He, Guixia Zhao, Wenzheng Jiang, Muhammad Asad Farooq, Yaoxin Gao, Mingyao Liu, Lei Tao, Li Zhang, Ying Zhou, Iqra Ajmal, Jie Yao
Publikováno v:
Cancers, Vol 12, Iss 2612, p 2612 (2020)
Cancers
Volume 12
Issue 9
Cancers
Volume 12
Issue 9
B cell aplasia caused by &ldquo
on-target off-tumor&rdquo
toxicity is one of the clinical side effects during CD19-targeted chimeric antigen receptor (CAR) T (CD19-CAR-T) cells treatment for B cell malignancies. Persistent B cell aplasia wa
on-target off-tumor&rdquo
toxicity is one of the clinical side effects during CD19-targeted chimeric antigen receptor (CAR) T (CD19-CAR-T) cells treatment for B cell malignancies. Persistent B cell aplasia wa